Microsoft has discontinued support for Internet Explorer. To access the Tarter website, please install a modern browser like Microsoft Edge or Google Chrome.
This website does not track your personal or demographic information, only anonymous usage statistics. To ensure that you are not tracked, we have blocked all embedded content from third party sources like YouTube and SlideShare. Click "Accept Cookies" to enable third-party content. To learn more about our cookie policy,click here.
Intellectual Property Group co-chair Philip Braginsky authored an article featured in Medical Device and Diagnostic Industry (MD+DI) titled, “Patent Considerations for Connected Medical Devices.” In the article, Phil discusses why developing new solutions, the Internet of Things (IoT) and Blockchain must be important components of a medtech company’s strategic planning.
Phil notes that “Early adopters may achieve certain benefits in their licensing efforts since they might be granted greater rights in participating in, or have some influence over, the continued development of a platform’s technology.” Nevertheless, “Those who wait may benefit from a clearer picture of the more widely used and successful IoT/blockchain platforms, thereby averting potentially costly mistakes.”